journal
Journals Transplant Infectious Disease ...

Transplant Infectious Disease : An Official Journal of the Transplantation Society

https://read.qxmd.com/read/38430479/multifocal-cutaneous-mycobacterium-ulcerans-infection-in-a-heart-transplant-recipient
#21
LETTER
Aadith Ashok, Victoria M Warner, Bradley J Gardiner
No abstract text is available yet for this article.
March 2, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38407514/interesting-case-from-argentina-kidney-transplant-recipient-with-skin-lesions-a-latin-american-perspective
#22
JOURNAL ARTICLE
Marcelo Víctor Radisic, Guilherme Santoro Lopes, Alejandro Marcel Hasslocher-Moreno, Emily M Eichenberger, Victoria G Hall, Natalia Rosana Pujato, Wanessa Trindade Clemente
This is a case of a kidney transplant recipient who presented with skin lesions, low-grade fevers, and pancytopenia 2 months after his transplant.
February 26, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38407512/underrecognized-cause-diarrhea-in-solid-organ-transplant-a-report-of-astroviridae-enteritis-in-liver-transplant
#23
JOURNAL ARTICLE
Parker Wilson, Craig Rosenstengle, Cedric Spak
We present a case of a 72-year-old liver transplant recipient 7 years prior who presents to our hospital with general malaise, fatigue, low-grade fevers, and watery diarrhea. He was found to have Astrovirus via PCR testing in a comprehensive stool panel. The patient's home mycophenolic acid was held upon admission, while cyclosporine was continued through his hospital stay. Generally, Astroviridae infection is a rarely identified cause of enteritis and even less so in the transplant population. Although reports have been published regarding devastating cases of encephalitis in immunocompromised patients, our patient did not exhibit these symptoms and draws into question the danger of this virus in other immunosuppressed populations...
February 26, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38375963/current-management-of-sars-cov-2-infection-in-solid-organ-transplant-recipients-experience-derived-from-an-esgich-esot-survey
#24
JOURNAL ARTICLE
Alessandro Visentin, Elise Pickavance, Rafael San-Juan, Paolo Antonio Grossi, Oriol Manuel, Jose M Aguado
OBJECTIVE: Solid organ transplant (SOT) recipients have a poorer SARS-CoV-2 vaccine response and higher risk for COVID-19-associated complications. However, there is no consensus on the current management of COVID-19 and data on persistent COVID-19 rates in SOT recipients are lacking. METHODS: An electronic survey concerning the management of COVID-19 in SOT recipients was distributed among all members of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Infections in Compromised Hosts (ESGICH) and of the European Society for Organ Transplantation (ESOT)...
February 20, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38375958/evolution-of-the-impact-of-the-covid-19-pandemic-on-heart-transplant-recipients-decreasing-risk-improving-perspective
#25
JOURNAL ARTICLE
Juan Carlos López-Azor García, Irene Marco, Javier González Martín, Francisco López-Medrano, Andrea Eixerés-Esteve, Pedro Caravaca Pérez, Javier de Juan Bagudá, Elena Ana López-Jiménez, Fernando Arribas, Juan Francisco Delgado-Jiménez, María Dolores García-Cosío Carmena
BACKGROUND AND METHODS: Heart transplant recipients (HTr) have a higher probability of suffer from severe coronavirus disease-2019 (COVID-19) in comparison to general population, but their risk has changed over the course of the pandemic in relation to various factors. We conducted a prospective study including all HTr at risk of COVID-19 in a tertiary center between February 2020 and October 2022. The aim was to analyze how the prognosis (incidence of pneumonia and mortality) of COVID-19 in HTr has evolved over time, contextualizing variants, vaccination, and other treatments...
February 20, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38375954/designing-and-analyzing-studies-of-coronavirus-disease-2019-and-post-acute-sequelae-of-severe-acute-respiratory-syndrome-coronavirus-2-among-immunocompromised-individuals
#26
EDITORIAL
Victor DeGruttola, Saima Aslam
Observational studies of coronavirus disease 2019 (COVID-19) among transplant candidates and recipients remain important as immunocompromised patients formed a very small proportion of patients included in COVID-19 trials and large database analyses. We discuss methods that have been used in such analyses to evaluate the impact of vaccination on the risk of symptomatic COVID-19 in such patients and on the probability of developing post-acute sequelae of severe acute respiratory syndrome coronavirus 2 after the onset of infection...
February 20, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38375929/disseminated-scedosporium-infection-in-the-early-post-kidney-transplant-period
#27
LETTER
Madhumita Rao, Michael Casias, Maheen Z Abidi
No abstract text is available yet for this article.
February 20, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38351512/management-of-infectious-disease-syndromes-in-thoracic-organ-transplants-and-mechanical-circulatory-device-recipients-a-delphi-panel
#28
JOURNAL ARTICLE
Me-Linh Luong, Yoshiko Nakamachi, Fernanda P Silveira, Catherine O Morrissey, Lara Danziger-Isakov, Erik A M Verschuuren, Cameron R Wolfe, Denis Hadjiliadis, Daniel C Chambers, Jignesh K Patel, Goran Dellgren, Miranda So, Geert M Verleden, Emily A Blumberg, Robin Vos, Michael Perch, Are M Holm, Nicholas J Mueller, Cecilia Chaparro, Shahid Husain
PURPOSE: Antimicrobial misuse contributes to antimicrobial resistance in thoracic transplant (TTx) and mechanical circulatory support (MCS) recipients. This study uses a modified Delphi method to define the expected appropriate antimicrobial prescribing for the common clinical scenarios encountered in TTx and MCS recipients. METHODS: An online questionnaire on managing 10 common infectious disease syndromes was submitted to a multidisciplinary Delphi panel of 25 experts from various disciplines...
February 13, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38351508/-not-available
#29
JOURNAL ARTICLE
Giovanni Mulé, Jean de Ville de Goyet, Alessandra Mularoni
No abstract text is available yet for this article.
February 13, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38351494/clinical-outcomes-of-sars-cov-2-infection-in-kidney-transplant-recipients-on-belatacept-a-single-center-experience
#30
LETTER
Fionna Feller, Marwan M Azar, Jennifer Marvin, Elizabeth Cohen, Sarthak Virmani, Maricar Malinis
No abstract text is available yet for this article.
February 13, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38349035/approach-to-febrile-neutropenia-in-patients-undergoing-treatments-for-hematologic-malignancies
#31
REVIEW
Erica J Stohs, Anum Abbas, Alison Freifeld
Febrile neutropenia (FN) is common among hematologic malignancy patients, including recipients of hematopoietic cell transplantation (HCT) and cellular therapies such as chimeric antigen receptor (CAR)-T-cell therapy. Prompt empiric antibiotic use has been the mainstay for decades but a "one-size-fits-all" approach is no longer broadly accepted, as treatment-related infectious risk are more understood. Growing antimicrobial resistance is an increasing clinical challenge. Evolving strategies on de-escalation of broad-spectrum antibiotics in FN without identified infection are areas of particular interest...
February 13, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38349023/the-nuts-and-bolts-of-transplant-infectious-disease-training
#32
JOURNAL ARTICLE
Courtney E Harris, Ghady Haidar, Ricardo M La Hoz, Chelsea A Gorsline, Rebecca N Kumar
The number of transplant infectious disease (TID) fellowship programs has expanded rapidly in the past 5 years, with the creation of many new programs and the expansion of training tracks and dedicated years as the demand for TID physicians grows drastically. This editorial focuses on major factors and complexities that programs should consider in TID fellowship creation, as well as highlighting examples of formative experiences, programmatic structure, and fellow resources that trainees can use to identify their desired career path in TID...
February 13, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38341645/a-multicenter-prospective-study-to-define-the-natural-history-of-bk-viral-infections-in-kidney-transplantation
#33
JOURNAL ARTICLE
Michael E Seifert, Roslyn B Mannon, Anoma Nellore, JoAnne Young, Alexander C Wiseman, David J Cohen, V Ram Peddi, Daniel C Brennan, Charity J Morgan, Kalyani Peri, Inmaculada Aban, Richard J Whitley, John W Gnann
BACKGROUND: BK polyomavirus (BKV) can cause permanent loss of allograft function due to BKV-associated nephropathy (BKVN) in kidney transplant recipients. Besides immunosuppression reduction, there are no consistently effective interventions for BKV infection. Study purpose was to define natural history of BKV infection, identify risk factors for BKV reactivation and BKVN in kidney transplant recipients, and inform the design/conduct of future clinical trials of BKV-targeted therapeutics...
February 11, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38319686/fecal-microbiota-transplantation-before-liver-transplant-in-patient-colonized-with-new-delhi-metallo-beta-lactamase-are-we-ready-for-a-sequential-approach
#34
LETTER
Silvia Martini, Teresa Zaccaria, Antonio Gasbarrini, Giovanni Cammarota, Renato Romagnoli, Gianluca Ianiro
No abstract text is available yet for this article.
February 6, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38319665/clinical-outcomes-of-baloxavir-versus-oseltamivir-in-immunocompromised-patients
#35
JOURNAL ARTICLE
Matthew Ringer, Maricar Malinis, Dayna McManus, Matthew Davis, Sunish Shah, Paul Trubin, Jeffrey E Topal, Marwan M Azar
BACKGROUND: Neuraminidase inhibitors, including oseltamivir, are the treatment standard for influenza. Baloxavir, a novel antiviral, demonstrated comparable outcomes to oseltamivir in outpatients with influenza. Baloxavir was equally effective as oseltamivir in a retrospective study of hospitalized patients with influenza at our institution. However, the efficacy of baloxavir in immunocompromised patients is unclear. METHODS: We conducted a retrospective cohort study of immunocompromised adult patients hospitalized with influenza A who received baloxavir from January 2019 to April 2019 or oseltamivir from January 2018 to April 2018...
February 6, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38291882/advancing-cytomegalovirus-prevention-in-solid-organ-transplant-recipients-the-promise-of-cell-mediated-immune-assays
#36
REVIEW
Vivek B Beechar, Varun K Phadke, Stephanie M Pouch, Michael H Woodworth
Cytomegalovirus (CMV) infections are a major source of morbidity and mortality in solid organ transplant recipients. Prophylactic, preemptive, and hybrid prevention strategies have traditionally been the mainstay of CMV prevention but there is growing interest in the use of CMV cell-mediated immune assays to inform novel approaches to risk stratification. Recent evidence suggests that CMV interferon-gamma release assays can offer predictive insights into the risk for CMV-related illnesses, raising the potential for tailored CMV prevention strategies anchored to each individual's unique CMV immune profile...
January 31, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38291879/chatgpt-and-strategies-for-safe-living-following-solid-organ-transplantation-correspondence
#37
LETTER
Hinpetch Daungsupawong, Viroj Wiwanitkit
No abstract text is available yet for this article.
January 30, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38269612/kidney-transplantation-in-patients-on-anti-tubercular-therapy-a-single-centre-observational-study
#38
JOURNAL ARTICLE
Pallavi Prasad, Sahil Bagai, Vandana Prasad, Rahul Grover, Gagandeep Chhabra, Dinesh Khullar
BACKGROUND: Tuberculosis (TB) is a common infection in chronic kidney disease. The prolonged therapy of TB can delay kidney transplantation in patients on antitubercular therapy (ATT). METHODS: This was a retrospective single-center study to analyze the safety of kidney transplantation and its outcomes in patients undergoing transplantation while on the continuation phase of ATT. RESULTS: Between 2013 and 2022, 30 patients underwent kidney transplantation while on ATT...
January 25, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38269469/the-addition-of-doxycycline-to-fluoroquinolones-for-bacterial-prophylaxis-in-autologous-stem-cell-transplantation-for-multiple-myeloma
#39
JOURNAL ARTICLE
Emma G Guare, Cory M Hale, Jeffrey Sivik, Erik Lehman, Yoshika Inoue, Kevin Rakszawski, Natthapol Songdej, Myles Nickolich, Hong Zheng, Seema Naik, David Claxton, Witold Rybka, Raymond Hohl, Shin Mineishi, Kentaro Minagawa, Catharine I Paules
BACKGROUND: Bacterial prophylaxis with a fluoroquinolone (FQ) during autologous stem cell transplant (ASCT) is common, although not standardized among transplant centers. The addition of doxycycline (doxy) to FQ prophylaxis was previously linked to reduced neutropenic fever and bacteremia in multiple myeloma (MM) patients undergoing ASCT although several confounders were present. We compared the incidence of neutropenic fever and bacteremia between MM patients variably receiving prophylaxis with FQ alone and FQ-doxy during ASCT...
January 25, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38269450/effect-of-sars-cov-2-preventive-measures-on-early-lung-transplant-fungal-acquisition-an-observational-study
#40
LETTER
Arnau Monforte, María Teresa Martin-Gomez, Ibai Los-Arcos, Ester Márquez-Algaba, Cristina Berastegui, Joel Rosado, Judith Sacanell, Joan Gavaldà, Oscar Len
No abstract text is available yet for this article.
January 25, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
journal
journal
34608
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.